계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
PvP Biologics
company
About
PvP Biologics is developing an oral enzyme for the treatment of celiac disease.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Nov 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
PvP Biologics is developing an oral enzyme for the treatment of celiac disease. Our mission is to develop a highly-effective therapeutic product to reduce the burden of living with this disease. Towards this end, we are advancing a product candidate designed to break down the immuno-reactive parts of gluten in the stomach and thereby avoid the painful symptoms and damage done in the small intestine from accidental gluten ingestion.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35M
PvP Biologics has raised a total of
$35M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2017 | Series Unknown | $35M | 1 |
Takeda
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
PvP Biologics is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Takeda
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
